State Street’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-216,110
| Closed | -$478K | – | 4654 |
|
|
2023
Q2 | $478K | Sell |
216,110
-9,900
| -4% | -$20.5K | ﹤0.01% | 3698 |
|
|
2023
Q1 | $574K | Hold |
226,010
| – | – | ﹤0.01% | 3698 |
|
|
2022
Q4 | $423K | Buy |
226,010
+17,900
| +9% | +$44.6K | ﹤0.01% | 3828 |
|
|
2022
Q3 | $535K | Sell |
208,110
-7,400
| -3% | -$18.4K | ﹤0.01% | 3753 |
|
|
2022
Q2 | $416K | Sell |
215,510
-609,030
| -74% | -$1.33M | ﹤0.01% | 3903 |
|
|
2022
Q1 | $2.45M | Buy |
824,540
+55,094
| +7% | +$207K | ﹤0.01% | 3485 |
|
|
2021
Q4 | $3.46M | Buy |
769,446
+11,011
| +1% | +$52.2K | ﹤0.01% | 3418 |
|
|
2021
Q3 | $3.69M | Buy |
758,435
+8,834
| +1% | +$48.7K | ﹤0.01% | 3394 |
|
|
2021
Q2 | $5.11M | Buy |
749,601
+59,720
| +9% | +$483K | ﹤0.01% | 3238 |
|
|
2021
Q1 | $4.87M | Sell |
689,881
-18,808
| -3% | -$135K | ﹤0.01% | 3065 |
|
|
2020
Q4 | $4.44M | Buy |
708,689
+16,923
| +2% | +$99.6K | ﹤0.01% | 3018 |
|
|
2020
Q3 | $3.74M | Buy |
691,766
+45,133
| +7% | +$223K | ﹤0.01% | 2925 |
|
|
2020
Q2 | $3.38M | Sell |
646,633
-5,925
| -0.9% | -$26.3K | ﹤0.01% | 2952 |
|
|
2020
Q1 | $2.06M | Sell |
652,558
-26,541
| -4% | -$97.9K | ﹤0.01% | 3061 |
|
|
2019
Q4 | $2.74M | Buy |
679,099
+5,320
| +0.8% | +$18.5K | ﹤0.01% | 3133 |
|
|
2019
Q3 | $2.91M | Buy |
673,779
+31,526
| +5% | +$126K | ﹤0.01% | 3071 |
|
|
2019
Q2 | $2.56M | Buy |
642,253
+58,810
| +10% | +$280K | ﹤0.01% | 3143 |
|
|
2019
Q1 | $3.13M | Buy |
583,443
+6,451
| +1% | +$41.7K | ﹤0.01% | 2977 |
|
|
2018
Q4 | $2.96M | Sell |
576,992
-1,927
| -0.3% | -$14.6K | ﹤0.01% | 2959 |
|
|
2018
Q3 | $5.62M | Buy |
578,919
+60,976
| +12% | +$615K | ﹤0.01% | 2809 |
|
|
2018
Q2 | $5.28M | Sell |
517,943
-109,128
| -17% | -$1.23M | ﹤0.01% | 2825 |
|
|
2018
Q1 | $8.15M | Buy |
627,071
+45,862
| +8% | +$683K | ﹤0.01% | 2559 |
|
|
2017
Q4 | $10.4M | Sell |
581,209
-7,842
| -1% | -$164K | ﹤0.01% | 2449 |
|
|
2017
Q3 | $14.8M | Sell |
589,051
-27,061
| -4% | -$630K | ﹤0.01% | 2226 |
|
|
2017
Q2 | $14.8M | Buy |
616,112
+325,856
| +112% | +$7.2M | ﹤0.01% | 2190 |
|
|
2017
Q1 | $5.59M | Buy |
290,256
+52,164
| +22% | +$822K | ﹤0.01% | 2648 |
|
|
2016
Q4 | $3.67M | Buy |
238,092
+42,117
| +21% | +$547K | ﹤0.01% | 2846 |
|
|
2016
Q3 | $2.55M | Buy |
195,975
+35,284
| +22% | +$468K | ﹤0.01% | 2874 |
|
|
2016
Q2 | $2.23M | Buy |
160,691
+486
| +0.3% | +$7.16K | ﹤0.01% | 2987 |
|
|
2016
Q1 | $2.43M | Buy |
160,205
+14,600
| +10% | +$223K | ﹤0.01% | 2923 |
|
|
2015
Q4 | $2.77M | Buy |
145,605
+6,440
| +5% | +$123K | ﹤0.01% | 2864 |
|
|
2015
Q3 | $2.65M | Buy |
139,165
+33,631
| +32% | +$838K | ﹤0.01% | 2867 |
|
|
2015
Q2 | $2.72M | Buy |
+105,534
| New | +$2.99M | ﹤0.01% | 2942 |
|
State Street's PRTK Position: Q3 2023 in Review
State Street sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q3 2023, closing a stake of 216,110 shares — an estimated $478K sold.
State Street first reported a position in PRTK in Q2 2015 and held it in 33 quarters. The position peaked at $14.8M in Q2 2017. 0 funds tracked by Wall St. Rank hold PRTK as of Q3 2023.
- State Street reported no remaining Paratek Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
- State Street sold 216,110 Paratek Pharmaceuticals, Inc. shares in Q3 2023, an estimated $478K.
- State Street first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2015 and held it in 33 quarters.
- State Street's Paratek Pharmaceuticals, Inc. position peaked at $14.8M in Q2 2017.
- 0 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q3 2023.
Based on State Street's 13F filing for Q3 2023, filed 14 Nov 2023.